Incidence Trends and Survival Prediction of Malignant Skin Cancer: A SEER-Based Study

References

• Ingraffea A. Melanoma. Facial Plast Surg Cl. 2013;21(1):33. doi:10.1016/j.fsc.2012.11.007
   PubMed Web of Science ®Google Scholar
• Lin Z, Du J, Lu C, Wang J. Risk factors of new symptomatic vertebral compression fractures after percutaneous vertebroplasty. Int J Clin Exp Med. 2019;12(1):949–954.
   Web of Science ®Google Scholar
• Tuong W, Cheng LS, Armstrong AW. Melanoma: epidemiology, diagnosis, treatment, and outcomes. Dermatol Clin. 2012;30(1):113. doi:10.1016/j.det.2011.08.006
   PubMed Web of Science ®Google Scholar
• Ahmed B, Qadir MI, Ghafoorb S. Malignant melanoma: skin cancer-diagnosis, prevention, and treatment. Crit Rev Eukar Gene. 2020;30(4):291–297. doi:10.1615/CritRevEukaryotGeneExpr.2020028454
   PubMed Web of Science ®Google Scholar
• Liu-Smith F, Jia J, Zheng Y. UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. Adv Exp Med Biol. 2017;996:27–40.
   PubMed Web of Science ®Google Scholar
• Ploydaeng M, Rajatanavin N, Pinyowiwat P. 15106 Prevalence of skin cancer, photoprotection behaviors, and photoaging in a Southeast Asian population. J AM ACAD Dermatol. 2020;83(6S). doi:10.1016/j.jaad.2020.06.651
   Google Scholar
• Han WH, Yong SS, Tan LL, et al. Characteristics of skin cancers among adult patients in an urban Malaysian population. Australas J Dermatol. 2019;60(4):E327–E329. doi:10.1111/ajd.13106
   PubMed Web of Science ®Google Scholar
• Kim HS, Ahn HS. Response to “the incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea” - reply from the authors. Brit J Dermatol. 2020;183(6):1150–1151. doi:10.1111/bjd.19465
   PubMed Web of Science ®Google Scholar
• Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. Ca Cancer J Clin. 2012;62(2):118–128. doi:10.3322/caac.20141
   PubMed Web of Science ®Google Scholar
• Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol. 2005;44(12):1016–1021. doi:10.1111/j.1365-4632.2004.02322.x
   PubMed Web of Science ®Google Scholar
• Cakir BO, Adamson P, Cingi C. Epidemiology and economic burden of non melanoma skin cancer. Facial Plast Surg Cl. 2012;20(4):419. doi:10.1016/j.fsc.2012.07.004
   PubMed Web of Science ®Google Scholar
• De La Torre-lugo EM, Figueroa LD, Sanchez JL, Morales-Burgos A, Conde D. Skin cancer in Puerto Rico: a multiannual incidence comparative study. P R Health Sci J. 2010;29(3SI):312–316.
   PubMedGoogle Scholar
• Fillon M. Darker-skinned patients have lower cancer survival rates. J Natl Cancer Inst. 2016;108(11):11. doi:10.1093/jnci/djw285
   Google Scholar
• Charles AJ, Otley CC, Pond GR. Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: implications for selecting surgical candidates. J Am Acad Dermatol. 2002;47(3):419–422. doi:10.1067/mjd.2002.122740
   PubMed Web of Science ®Google Scholar
• de Vries E, Steliarova-Foucher E, Spatz A, Ardanaz E, Eggermont AMM, Coebergh JWW. Skin cancer incidence and survival in European children and adolescents (1978–1997). report from the automated childhood cancer information system project. Eur J Cancer. 2006;42(13):2170–2182. doi:10.1016/j.ejca.2006.07.001
   PubMed Web of Science ®Google Scholar
• Dunn EC, Moore KJ, Miao F, Kirsner RS, Koru-Sengul T. Survival of children and young adults with skin cancer: analysis of a population-based Florida cancer registry: 1981–2013. Pediatr Dermatol. 2018;35(5):597–601. doi:10.1111/pde.13588
   PubMed Web of Science ®Google Scholar
• Eisemann N, Waldmann A, Katalinic A. Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein. Bundesgesundheitsbla. 2014;57(1):77–83. doi:10.1007/s00103-013-1876-1
   Google Scholar
• Kai Y, Ishikawa K, Goto M, et al. Results of second-stage screening for skin cancers in Oita Prefecture, Japan. J Dermatol. 2015;42(12):1160–1164. doi:10.1111/1346-8138.13016
   PubMed Web of Science ®Google Scholar
• Bander TS, Nehal KS, Lee EH. Cutaneous squamous cell carcinoma updates in staging and management. Dermatol Clin. 2019;37(3):241. doi:10.1016/j.det.2019.03.009
   PubMed Web of Science ®Google Scholar
• Graefen M, Augustin H, Karakiewicz PI, et al. Can nomograms derived in the US applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy. Urologe A. 2003;42(5):685. doi:10.1007/s00120-002-0251-x
   PubMedGoogle Scholar
• Dotan ZA, Ramon J. Nomograms as a tool in predicting prostate cancer prognosis. Eur Urol Suppl. 2009;8(9):721–724. doi:10.1016/j.eursup.2009.06.013
   Web of Science ®Google Scholar
• Borque Fernando A, Esteban Escano LM, Sanz Saiz G, Rioja Sanz LA. Predictive models for biochemical recurrence of prostate cancer after local treatment nomograms. Arch Esp Urol. 2012;65(1):39–50.
   PubMed Web of Science ®Google Scholar
• Hinev AI, Anakievski D, Kolev NH, Hadjiev VI. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection. Urol Int. 2014;92(3):300–305. doi:10.1159/000354323
   PubMed Web of Science ®Google Scholar
• Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore cancer registry data 1968–97. Brit J DermatoL. 2003;148(6):1161–1166. doi:10.1046/j.1365-2133.2003.05223.x
   PubMed Web of Science ®Google Scholar
• Stern RS. Prevalence of a history of skin cancer in 2007 results of an incidence-based model. Arch Dermatol. 2010;146(3):279–282. doi:10.1001/archdermatol.2010.4
   PubMed Web of Science ®Google Scholar
• Rundle CW, Militello M, Barber C, Presley CL, Rietcheck HR, Dellavalle RP. Epidemiologic burden of skin cancer in the US and worldwide. Curr Dermatol Rep. 2020;9(4):309–322. doi:10.1007/s13671-020-00311-4
   Web of Science ®Google Scholar
• Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review. J Am Acad Dermatol. 2017;76(1):129. doi:10.1016/j.jaad.2016.07.045
   PubMed Web of Science ®Google Scholar
• Eisemann N, Waldmann A, Geller AC, et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):43–50. doi:10.1038/jid.2013.304
   PubMed Web of Science ®Google Scholar
• Schmerling RA, Loria D, Cinat G, et al. Cutaneous melanoma in Latin America: the need for more data. Rev Panam Salud Publ. 2011;30(5):431–438. doi:10.1590/S1020-49892011001100005
   PubMed Web of Science ®Google Scholar
• Dimitriou F, Krattinger R, Ramelyte E, et al. The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep. 2018;20(11):11. doi:10.1007/s11912-018-0732-8
   PubMed Web of Science ®Google Scholar
• Claudia A, Tomohiro M, Veronica DC, et al. Global surveillance of trends in cancer survival 2000–14 (concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song Y, Gao Q. Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: a case report and literature review. Oncol Lett. 2015;10(2):883–886.
   PubMed Web of Science ®Google Scholar
• Abegaz TM, Ayele AA, Gebresillassie BM. Health related quality of life of cancer patients in Ethiopia. J Oncol. 2018;2018:1467595. doi:10.1155/2018/1467595
   PubMed Web of Science ®Google Scholar
• Luo P, Zhou J, Jin S, Qing M, Ma H. Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database. J Ovarian Res. 2019;12(1). doi:10.1186/s13048-019-0600-7
   Web of Science ®Google Scholar
• Sartorius B, Veerman LJ, Manyema M, Chola L, Hofman K. Determinants of obesity and associated population attributability, South Africa: empirical evidence from a national panel survey, 2008–2012. PLoS One. 2015;10:6. doi:10.1371/journal.pone.0130218
   Web of Science ®Google Scholar
• O’Shea SJ, Rogers Z, Warburton F, Ramirez AJ, Newton-Bishop JA, Forbes LJL. Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study. BMC Cancer. 2017;17(1). doi:10.1186/s12885-016-2978-6
   PubMed Web of Science ®Google Scholar
• Metri R, Mohan A, Nsengimana J, et al. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach. Sci Rep Uk. 2017;7(1):1–4.
   PubMedGoogle Scholar
• Herbreteau G, Vallee A, Knol A, et al. Circulating tumour DNA Is an independent prognostic biomarker for survival in MetastaticBRAForNRAS-mutated melanoma patients. Cancers. 2020;12(7). doi:10.3390/cancers12071871
   PubMed Web of Science ®Google Scholar
• Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun. 2019;39(1):1–9.
   Web of Science ®Google Scholar
• Lancellotta V, Luis Guinot J, Fionda B, et al. SKIN-COBRA (consortium for brachytherapy data analysis) ontology: the first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer. J Contemp Brachyther. 2020;12(2):105–110. doi:10.5114/jcb.2020.94579
   PubMed Web of Science ®Google Scholar